MARKET

NAVB

NAVB

NAVIDEA BIOPHARM
AMEX

Real-time Quotes | Nasdaq Last Sale

0.6881
-0.0214
-3.02%
Closed 16:00 11/15 EST
OPEN
0.7000
PREV CLOSE
0.7095
HIGH
0.7200
LOW
0.6801
VOLUME
45.93K
TURNOVER
--
52 WEEK HIGH
4.400
52 WEEK LOW
0.4900
MARKET CAP
12.44M
P/E (TTM)
-0.5480
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NAVB and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NAVB News

  • Edited Transcript of NAVB earnings conference call or presentation 7-Nov-19 10:00pm GMT
  • Thomson Reuters StreetEvents.10h ago
  • Navidea Biopharmaceuticals to Present at the PCG Spotlight Series Conference
  • Business Wire.2d ago
  • What Kind Of Shareholders Own Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB)?
  • Simply Wall St..3d ago
  • Navidea Biopharmaceuticals' (NAVB) CEO Jed Latkin on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.11/09 11:44

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About NAVB

Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple precision-targeted products based on the Manocept platform to help identify the sites and pathways of undetected disease. The Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on activated macrophages. NAV5001 is an iodine-123 (I-123) radiolabeled single-photon emission computed tomography (SPECT) imaging agent being developed as an aid in the diagnosis of Parkinson's disease (PD) and other movement disorders, with potential use as a diagnostic aid in dementia. NAV4694 is a fluorine-18 (F-18) radiolabeled positron emission tomography (PET) imaging agent being developed as an aid in the diagnosis of patients with signs or symptoms of Alzheimer's disease (AD) and mild cognitive impairment (MCI).
More

Webull offers Navidea Biopharmaceuticals Inc (NAVB) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.